M. Desbiens
Director/Board Member at APTILON CORPORATION
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michel Bazinet | M | 68 |
Replicor, Inc.
 Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | 21 years |
| Denis Martineau | M | 34 | 19 years | |
| André Brosseau | M | 62 | 19 years | |
| Justin Francis Beckett | M | 60 | 16 years | |
| Bertrand Bolduc | M | - | 6 years | |
| Peter Edwards | M | 62 | 4 years | |
| Roger Korman | M | - | 18 years | |
| André Charron | M | - | - | |
| Paul Vander Plaetse | M | - |
VuWall Technology, Inc.
 VuWall Technology, Inc. Packaged SoftwareTechnology Services VuWall Technology, Inc. provides visualization software solutions for professional applications. It offers video wall control and collaboration, AV network management, scheduling and transition management, presentation system, and video wall controllers. The company was founded by Paul Vander Plaetse in 2009 and is headquartered in Pointe-Claire, Canada. | 15 years |
| Gérard Antoine Limoges | M | 84 |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
| Dennis Turpin | M | - | 3 years | |
| Andrew Vaillant | M | - |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
| Moneesh Chatterjee | M | - |
Replicor, Inc.
Replicor, Inc. Pharmaceuticals: OtherHealth Technology Replicor, Inc. operates as a biopharmaceutical company which develops and commercializes novel nucleic acid-based polymers. The company is headquartered in Montreal, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Benthin | M | - | 13 years | |
| H. Norton | M | 63 | 2 years | |
| Siegfried Hekimi | M | - |
Chronogen, Inc.
 Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 12 years |
| Yves Fouron | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
| Max Fehlmann | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 6 years |
| Pascal Puchois | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 5 years |
| Nahed K. Ahmed | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
| Jean-Marie Houle | M | - |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 4 years |
| Robin Hoke | F | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 22 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- M. Desbiens
- Personal Network
